Vaccine
Safety > Research
Vaccine Safety
and Development
Locating Information on
Vaccine Safety
National Immunization
Program
January 2000
Jump to:
Internet
Resources
Resources to Help Address Vaccine Myths
Vaccine-Related Publications
State and Local Agencies
Federal Agencies and Programs
International Organizations
Other Resource Organizations
Note: This publication is presented
for information purposes only, and no claims of accuracy are made.
Mention of trade names, commercial products, or organizations does
not constitute endorsement by the National Immunization Program
(NIP) or the Centers for Disease Control and Prevention (CDC).
Introduction
This guide was produced
by the National Immunization Program, Vaccine Safety and Development
Activity, part of the Centers for Disease Control and Prevention,
to help individuals research issues surrounding vaccine safety.
A large portion of this guide is devoted to identifying search tools
and resources that are available electronically over the Internet.
This document also contains descriptions of selected vaccine-related
publications, government agencies involved in national immunization
efforts and vaccine control, and organizations that can provide
pertinent information or assistance.
The Internet is a valuable, ever
growing resource of health-related information. Before you start
searching the Internet, you should be aware that not all information
posted on the Web is valuable or accurate, and it is not always
possible to determine the credibility of every Web site. You can
use the following Web sites as starting points that provide useful
information and/or links to many other sites of interest:
National Immunization Program
Web site: www.cdc.gov/nip
Web site on vaccine safety: www.cdc.gov/nip/vacsafe
National Immunization Information
Hotline
(800) 232-2522 (English),
(800) 232-0233 (Spanish)
Healthfinder
Web site: www.healthfinder.gov
A gateway to consumer health-related
information available on the Internet maintained by the U.S. Department
of Health and Human Services, this site links to online publications,
clearinghouses, databases, Web sites, and support and self-help
groups, as well as government agencies and non-profit organizations.
The Immunization Gateway:
Your Vaccine Fact-Finder
Web site: www.immunofacts.com
This site is an online vaccine/immunization
fact finder that links to many of the latest resources on vaccines.
It is produced by Facts and Comparisons, a commercial publisher
of drug-related information.
Medscape
Web site: www.medscape.com
Medscape has a combination of information
from clinical journals, medical news providers, medical education
programs, and materials created expressly for Medscape. Access
to Medscape is free, but requires a one-time membership registration.
The Vaccine Page
Web site: vaccines.com/index.html
This page contains up-to-date information
about immunizations for several distinct audiences including parents,
practitioners, and researcher. Vaccine related online journals
are also available. This site is produced by UniScience News Net,
producer of a daily science news page.
National Library of Medicine
Resources
Web site: www.nlm.nih.gov
Service Desk: (888) FIND-NLM
Comprehensive medical and health
information through MEDLARS (Medical Literature Analysis and Retrieval
System) and MEDLINE. These resources can generally be accessed
at medical or university libraries. They are also available at
no cost through Internet Grateful Med and Pub Med.
Internet Grateful Med
Web site: igm.nlm.nih.gov
Internet Grateful Med offers assisted
searching of MEDLINE and other NLM databases, including HealthSTAR
(non-clinical planning and health care delivery citations) and
HSRPROJ (detailed descriptions of ongoing health research projects).
PubMed
Web site: www.ncbi.nlm.nih.gov/pubmed
PubMed also accesses MEDLINE with
the enhanced abilities to combine more than one search and to
automatically retrieve related items. When conducting a database
search in MEDLINE, it is helpful to be familiar with the subject
terms, officially called the Medical Subject Headings (MeSH),
consistently used throughout the database. If you use a MeSH term,
your search will be more precise, retrieving more relevant records
and eliminating "false hits" or records that are not
really relevant. To retrieve vaccine-related information use the
terms vaccination, specific adverse events (e.g. arthritis, SIDS)
and specific vaccine-preventable diseases of interest (e.g. chickenpox,
diphtheria).
National Immunization Program
Web site: www.cdc.gov/nip
Vaccine safety web site: www.cdc.gov/nip/vacsafe
National Immunization Information
Hotline
(800) 232-2522 (English), (800) 232-0233 (Spanish)
What Would Happen If we Stopped
Vaccinations (fact
sheet)
Web site document: www.cdc.gov/nip/vacsafe/fs/valuefs.htm
Six Common Misconceptions
About Vaccination and How to Respond to Them (1996)
National Immunization Program
Information and Distribution Center
Centers for Disease Control and Prevention
1600 Clifton Road NE, MS E-34
Atlanta, GA 30333
(800) 232-2522
FAX (404) 639-8828
Web site: www.cdc.gov/nip/publications/default.htm
Risk Communication and Vaccination: Workshop Summary
(1997)
National Academy Press
2101 Constitution Avenue, NW
P.O. Box 285
Washington, DC 20055
(800) 624-6242 or (202) 334-3313
Web site: http://www.nap.edu/readingroom/enter2.cgi?
0309057906.html
Vaccines: What Every Parent
Should Know (1999,
revised edition)
Authors: Paul A. Offit, MD and Louis M. Bell, MD
IDG Books World Wide, Inc
New York, New York
Vaccine Safety: What Parents
Need to Know (pamphlet)
Michigan Department of Community Health
Information & Education Coordinator
Division of Immunization
3423 N. M.L. King Blvd, PO Box 30195
Lansing, Michigan 48909
1-888-76-SHOTS
What if You Don’t Immunize
Your Child? (pamphlet)
California Department of Health Services
Immunization Branch
2151 Berkeley Way, Room 712
Berkeley, CA 94704
Plain Talk About Childhood
Immunizations (booklet)
Washington Department of Health
Immunization Program
New Market Industrial Campus, Bldg. 1
PO Box 47843
Olympia, WA 98504-7843
State of Alaska, Section
of Epidemiology
Immunization Program
3601 C Street, Suite 540
Anchorage, Alaska 99503
(907) 269-8000
Other State Immunization Programs (Appendix G) may have materials
they developed to address myths and misinformation regarding vaccines.
Journal Articles
that provide important information
to address myths and misinformation:
Gangarosa EJ, Galazka AM, Wolfe
CR, Phillips LM, Gangarosa RE, Miller E, Chen RT. Impact of the
anti-vaccine movements on pertussis control: the untold story.
Lancet 1998;351:356-61.
Salmon DA, Haber M, Gangarosa EJ,
Phillips L, Smith NJ, Chen RT. Health consequences of religious
and philosophical exemptions from immunization laws: individual
and societal risk of measles. J Am Med Assoc 1999;282:47-53.
Adverse Events Associated
with Childhood Vaccines: Evidence Bearing on Causality
(1994)
National Academy Press
2101 Constitution Avenue, NW
P.O. Box 285
Washington, DC 20055
(800) 624-6242 or (202) 334-3313
Web site: www.nap.edu
This volume provides a literature
review about common childhood vaccines for tetanus, diphtheria,
measles, mumps, polio, Hib, and hepatitis B. It presents findings
in tables and narrative, discusses approaches to evidence and
causality, and examines the possible adverse effects, including
neurologic and immunologic disorders and death. Helpful background
information on the development of vaccines, detailed case reports,
clinical trials, and other evidence associating each vaccine with
specific disorders are included.
Adverse Effects of Pertussis
and Rubella Vaccines
(1991)
National Academy Press
2101 Constitution Avenue, NW
P.O. Box 285
Washington, DC 20055
(800) 624-6242 or (202) 334-3313
Web site: www.nap.edu
This book examines the relationship
of rubella and pertussis vaccines to a number of serious adverse
events based on an extensive review of evidence from epidemiologic
studies, case histories, studies in animals, and other sources
of information.
Epidemiology
and Prevention of Vaccine-Preventable Diseases
(8th
edition, 2004) UPDATED!
Produced by the National Immunization
Program, Centers for Disease Control and Prevention
Published and distributed by the
Public Health Foundation
(877) 252-1200
$29 + S/H
Web site: http://bookstore.phf.org/cat5.htm
This book provides an overview
of vaccine-preventable infectious diseases and the corresponding
vaccines.
Immunofacts
Facts and Comparisons, Inc.
111 West Port Plaza, Suite 400
St. Louis, MO 63146-3098
(800) 223-0554
FAX (314) 878-5563
This book provides comprehensive,
technical information on specific vaccines, indications, product
availability, dosage, safety and a glossary of terms.
Parents Guide to Childhood
Immunization (2001)
National Immunization Program
Information and Distribution Center
Centers for Disease Control and Prevention
1600 Clifton Road NE, MS E-34
Atlanta GA 30333
(800) 232-2522
FAX (404) 639-8828
Web site: www.cdc.gov/nip/publications/default.htm
This booklet, available in English
and Spanish, is designed for parents and discusses vaccines, vaccine-preventable
diseases, and possible vaccine side effects.
Risk Communication and Vaccination:
Workshop Summary (1997)
National Academy Press
2101 Constitution Avenue, NW
P.O. Box 285
Washington, DC 20055
(800) 624-6242 or (202) 334-3313
Web site: http://www.nap.edu/readingroom/enter2.cgi
?0309057906.html
In 1995, the Institute of Medicine
(IOM) established the Vaccine Safety Forum to examine issues relating
to vaccine safety. On May 13, 1996, the forum held a work shop
on risk communication and vaccination. The topics included key
concepts in risk communication, current practices, vaccine risks
versus disease risks and vaccine failure. This document summarizes
the workshop.
Six Common Misconceptions
About Vaccination and How to Respond to Them
(1996)
National Immunization Program
Information and Distribution Center
Centers for Disease Control and Prevention
1600 Clifton Road NE, MS E-34
Atlanta GA 30333
(800) 232-2522
FAX (404) 639-8828
Web site: www.cdc.gov/nip/publications/default.htm
This booklet discusses six misconceptions
about vaccination often cited by parents as reasons they question
the need to have their children immunized. Each misconception
is refuted based on scientific information and research findings.
The misconceptions include (1) diseases already began to disappear
before vaccines were introduced because of better hygiene and
sanitation; (2) the majority of people who get a disease have
been vaccinated; (3) so-called "hot lots" of vaccines
have been associated with more adverse events and deaths than
others, and parents should identify the numbers of these lots
and not allow their children to receive vaccines from them; (4)
vaccines cause harmful side effects, illnesses, and even death;
(5) vaccine-preventable diseases have been virtually eliminated
in the United States, so there is no need for vaccination; and
(6) giving a child multiple vaccinations for different diseases
at the same time increases the risk of harmful side effects and
can overload the immune system.
Understanding the Immune
System (1993)
National Institutes of Health
National Institute of Allergy and Infectious Diseases
NIH Publication No. 93-529
NIAID Office of Communications and Public Liaison
Building 31, Room 7A-50
31 Center Drive MSC 2520
Bethesda, MD 20892-2520
http://rex.nic.nih.gov/PATIENTS/INFO_TEACHER/
bookshelf/NIH_immune/index.html
This booklet provides information
on the anatomy of the immune system, natural and acquired immunity,
and disorders of the immune system.
Understanding Vaccines
(1998)
National Institutes of Health
National Institute of Allergy and Infectious Diseases
NIH Publication No. 98-4219
NIAID Office of Communications and Public Liaison
Building 31, Room 7A-50
31 Center Drive MSC 2520
Bethesda, MD 20892-2520
http://www.niaid.nih.gov/publications/vaccine/
undvacc.htm
This booklet provides a general
overview of the immune system, the different types of vaccines,
the development phase, FDA licensure and vaccines of the future.
Vaccine Safety Forum: Summaries
of Two Workshops
(1997)
Board on Health Promotion and Disease
Prevention, Institute of Medicine
National Academy Press, 2101 Constitution Ave., NW
P.O. Box 285
Washington DC 20055
(800) 624-6242
FAX (202) 334-3313
Web site: www.nap.edu
This report summarizes the proceedings
of the following two workshops: (1) Detecting and Responding to
Adverse Events Following Vaccination, which was held on November
6, 1995, and (2) Research to Identify Risks for Adverse Events
Following Vaccination: Mechanisms and Possible Means of Prevention,
which was conducted on April 1, 1996. Topics of the first workshop
included difficulties in detecting adverse events, current adverse
events detection and response methods and procedures, suggestions
for improving the means of detecting and responding to adverse
events following vaccination, and future areas of research. The
second workshop addressed immunologic and genetic factors that
might influence individual vaccine responses, current research
to identify which populations are at increased risk for experiencing
adverse events from vaccines, and research needs.
Vaccine Weekly
CW Henderson Customer Service
P.O. Box 830409
Birmingham AL 35283-0409
(800) 633-4931
FAX (205) 995-1588
This weekly newsletter contains
the latest information available on vaccine-related research around
the world. Topics include therapeutic vaccines for AIDS and other
diseases, efficacy and safety trials, FDA approvals, and much
more. Other vaccine-related newsletters include: Hepatitis Weekly,
Immunotherapy Weekly, and Tuberculosis and Airborne Disease Weekly.
A partial glimpse is available weekly via the Internet at: www.homepage.holowww.com.
Vaccines (1999) Chen,
RT. Safety of Vaccines. Chapter 49, page 1144-63.
Authors: Plotkin SA, Orenstein
WA, eds.
W.B. Saunders Company
P.O. Box 628239
Orlando FL 32862-8239
(800) 545-2522
FAX (800) 874-6418
Web site: customerservice.wbsaunders.com
wbsbcs@harcourtbrace.com
This book discusses specific vaccines
and related issues. Of particular interest are chapters covering
the following topics: safety of vaccines; regulation and testing
of vaccines; public health considerations; US law, and the National
Vaccine Injury Compensation Program.
Vaccines and Related Biological
Products Advisory Committee: (Open Session) Post-Marketing Surveillance
of Vaccine Safety, August 24, 1994
Food and Drug Administration (FDA)
Freedom of Information
5600 Fishers Lane, HFI-35
Rockville, MD 20857
(301) 827-2000
FAX (301) 443-1726
This document is an edited transcript
of the proceedings of the Vaccine and Related Biological Products
meeting held in Bethesda, MD, on August 24, 1994. It contains
the portions of the proceedings covering vaccine safety. Topics
include: (1) Introduction to Vaccine Safety Issues; (2) Summary
of the Institute of Medicine Reports; (3) Scientific Background
on Vaccine Safety; (4) Vaccine Adverse Events Reporting System
(VAERS); (5) Interpretation of VAERS Data; (6) Using VAERS to
Monitor Vaccine Safety; (7) Methodological Approaches to Assessing
Vaccine Safety; (8) CDC Activities Related to Vaccine Safety;
and (9) Large-Linked Database Project.
Vaccines: What Every Parent
Should Know (1999,
revised edition)
Authors: Paul A. Offit, MD and
Louis M. Bell, MD
IDG Books World Wide, Inc
New York, New York
This book provides the answers
to questions that parents frequently ask their pediatrician about
vaccines. Topics include, safety, including vaccine additives
such as Thimerosal; myths about vaccines; routinely recommended
immunizations, and vaccines used in special situations (travel,
etc). This publication provides parents with the information they
require to make well-informed decisions about their child's health.
Journal Articles
CDC. National Childhood Vaccine
Injury Act: requirements for permanent vaccination records and
for reporting of selected events after vaccination. MMWR 1988;37:197-200.
CDC. Update: Vaccine side effects,
adverse reactions, contraindications and precautions. Recommendations
of the Advisory Committee on Immunization Practices (ACIP). MMWR
1996;45(RR-12):1-35.
Chen RT and Hibbs B. Vaccine safety:
current and future challenges. Ped Annals 1998;27:445-64.
Chen RT et al. The Vaccine Adverse
Event Reporting System (VAERS). (1994) Vaccine 12(6): 542-548.
Chen RT, Glasser J, Rhodes P, Davis
RL, Barlow WE, Thompson RS, Mullooly JP, Black SB, Shinefield
HR, Vadheim CM, Marcy SM, Ward JI, Wise RP, Wassilak SG, Hadler
SC. The Vaccine Safety Datalink Project: A New Tool for Improving
Vaccine Safety Monitoring in the United States. Pediatrics 1997;99:765-73.
Chen RT, Rastogi SC, Mullen JR,
et al. The Vaccine Adverse Event Reporting System (VAERS). Vaccine
1994;12:542-50.
Chen RT. Special methodological
issues in pharmacoepidemiology studies of vaccine safety. In:
Strom BL, ed. Pharmacoepidemiology. Sussex: John Wiley & Sons,
1994
Chen RT. Safety of Vaccines. Ch.
49 In: Plotkin SA, Orenstein WA, eds. Vaccines. Philadelphia:
WB Saunders, 1999:1144-63.
Chen RT. Vaccine risks: real, perceived,
and unknown. Vaccine 1999; 17: S41-6.
Chen RT and Orenstein WA. Epidemiologic
Methods in Immunization Programs. (1996) Epidemiologic Reviews
18(2):99-117.
Ellenberg SS and Chen RT. The complicated
task of monitoring vaccine safety. Public Health Reports
1997;112:10-20.
Gangarosa EJ, Galazka AM, Wolfe
CR, Phillips LM, Gangarosa RE, Miller E, Chen RT. Impact of the
anti-vaccine movements on pertussis control: the untold story.
Lancet 1998;351:356-61.
Grabenstein JD. Clinical Management
of Hypersensitivities to Vaccine Components.(1997) Hospital
Pharmacy 32(1):77-87.
Grabenstein JD. Immunologic Necessities:
Diluents, Adjuvants, and Excipients. (1996) Hospital Pharmacy
31(13):1387-1401.
Institute of Medicine. Adverse
effects of pertussis and rubella vaccines. Washington, D.C.: National
Academy Press, 1991.
Institute of Medicine. Adverse
events associated with childhood vaccines: evidence bearing on
causality. Washington, D.C.: National Academy Press, 1994.
Salmon DA, Haber M, Gangarosa EJ,
Phillips L, Smith NJ, Chen RT. Health consequences of religious
and philosophical exemptions from immunization laws: individual
and societal risk of measles. J Am Med Assoc 1999;282:47-53.
Stehlin IB. How FDA Works to Ensure
Vaccine Safety.(December 1995) FDA Consumer 29(10):6-10.
The National Chilhood Vaccine Injury
Act of 1986, at Section 2125 of the Public Health Service Act
as codified at 42 U.S.C. 300aa-Supp 1987.
Prevention Guidelines:
The following federal guidelines are available from:
The Centers for Disease Control
and Prevention
MMWR Series
1600 Clifton Road, MS C-08
Atlanta, GA 30333
Web site: www.cdc.gov/epo/mmwr/mmwr.html.
General Recommendations:
General Recommendations on Immunization.
January 28, 1994, MMWR, Vol. 43, No. RR-1.
Immunization of Adolescents. November
22, 1996, MMWR, Vol. 45, No. RR-13.
Immunization of Health Care Workers.
December 26, 1997, MMWR, Vol. 46, No. RR-18.
Update on Adult Immunization. November
15, 1991, MMWR, Vol. 40, No. RR-12.
Use of Vaccines and Immune Globulins
in Persons with Altered Immunocompetence. April 9, 1993, MMWR,
Vol. 42, No. RR-4.
Vaccines Recommended for
Routine Use in the United States
Diphtheria, Tetanus, Pertussis:
Recommendations for Vaccine Use and Other Preventative Measures.
August 8, 1991, MMWR, Vol. 40, No. RR-10.
Pertussis Vaccination: Use of Acellular
Pertussis Vaccine Among Infants and Young Children, March 28,
1997, MMWR, Vol. 46, No. RR-7.
Prevention of Hepatitis A Through
Active or Passive Immunization. MMWR 1999, Vol. 48, RR-12.
Hepatitis B Virus: A Comprehensive
Strategy for Eliminating Transmission in the United States Through
Universal Childhood Vaccination. November 22, 1991, MMWR, Vol.
40, No. RR-13.
Haemophilus b Conjugate Vaccines
for Prevention of Haemophilus Influenzae Type b Disease
Among Infants and Children Two Months of Age and Older. January
11, 1991, MMWR, Vol. 40, No. RR-1.
Recommendations for Use of Haemophilus
b Conjugate Vaccines and a Combined Diphtheria, Tetanus, Pertussis,
and Haemophilus b Vaccine. September 17, 1993, MMWR, Vol.
42, No. RR-13.
Prevention and Control of Influenza.
April 30, 1999, MMWR, Vol. 48, No. RR-4.
Measles, Mumps, and Rubella-Vaccine
Use and Strategies for Elimination of Measles, Rubella, and Congenital
Rubella Syndrome and Control of Mumps. May 23, 1998, MMWR, Vol.
47, No. RR-8.
Prevention of Pneumococcal Disease.
April 4, 1997, MMWR, Vol. 46, No. RR-8.
Poliomyelitis Prevention in the
United States: Introduction of a Sequential Vaccination Schedule
of Inactivated Poliovirus Vaccine Followed by Oral Poliovirus
Vaccine. January 24, 1997, MMWR, Vol. 46, No. RR-3.
Prevention of Varicella. July 12,
1996, MMWR, Vol. 45, No. RR-11.
Vaccines Used in Special Circumstances
or Populations
The Role of BCG Vaccine in the
Prevention and Control of Tuberculosis in the United States. April
26, 1996, MMWR, Vol. 45, No. RR-4.
Cholera Vaccine. October 14, 1988,
MMWR, Vol. 37, No. 40.
Inactivated Japanese Encephalitis
Virus Vaccine. January 8, 1993, MMWR, Vol. 42, No. RR-1.
Recommendations for the use of
Lyme Disease Vaccine. June 4, 1999. MMWR, Vol. 48, No. RR-7.
Control and Prevention of Meningococcal
Disease and Control and Prevention of Serogroup C Meningococcal
Disease: Evaluation and Management of Suspected Outbreaks. February
14, 1997, MMWR, Vol. 46, No. RR-5.
Prevention of Plague. December
13, 1996, MMWR, Vol. 45, No. RR-14.
Human Rabies Prevention-United
States, 1999. January 8, 1999, MMWR, Vol. 48, No. RR-1.
Typhoid Immunization. December
9, 1994, MMWR, Vol. 43, No. RR-14.
Vaccinia (Smallpox) Vaccine. December
13, 1991, MMWR, Vol. 40, No. RR-14.
Yellow Fever Vaccine. May 4, 1990,
MMWR, Vol. 39, No. RR-6.
Other
Programmatic Strategies to Increase
Vaccination Coverage by Age 2 Years-Linkage of Vaccination and
WIC Services. March 15, 1996, MMWR, Vol. 45, No. 10, pp. 217-218.
Programmatic Strategies to Increase
Vaccination Rates - Assessment and Feedback of Provider-Based
Vaccination Coverage Information. March 15, 1996, MMWR, Vol. 45,
No. 10, 219-220.
Update: Vaccine Side Effects, Adverse
Reactions, Contraindications, and Precautions. September 6, 1996,
MMWR, Vol. 45, No. RR-12.
For general information on immunization,
vaccine safety, clinics administering vaccines and school-entry
requirements, contact your state or local health department.
State Health Departments On-line:
www.cdc.gov/epo/mmwr/medassn.html#states
Immunization Grantees (National Immunization
Program), Program Managers - see Appendix G.
Centers for Disease Control
and Prevention (CDC)
National Immunization Program (NIP)
1600 Clifton Road, NE, MS E-05
Atlanta, GA 30333
E-mail: nipinfo@cdc.gov
Web site: www.cdc.gov/nip
Web site-Vaccine Safety: www.cdc.gov/nip/vacsafe
Find immunization clinics near
you and answers to questions about immunization -- (800) 232-2522
Spanish hotline providing
materials and referral services to callers who have questions
about immunization -- (800) 232-0233
Travelers' hotline (24 hours
a day, 7 days a week) information on requirements and recommendations
for the international traveler -- (877) 394-0747
Web site: www.cdc.gov/travel/index.htm.
NIP provides leadership for the
planning, coordination, and implementation of immunization activities
nationwide. The program helps monitor the safety and efficacy
of vaccines by linking vaccine administration information with
adverse event reporting and disease outbreak patterns. Through
its toll-free telephone numbers and Web site, NIP answers frequently
asked questions about vaccines, provides immunization schedules,
and distributes vaccine-related publications. It also produces
the Immunization Action News Memorandum, a bi-weekly newsletter
that contains the latest news and information concerning vaccinations.
CDC National Immunization Program
Data Management Division, Systems Development Branch
Immunization Registry Clearinghouse
1600 Clifton Road, NE, Mailstop
E-62
Atlanta, GA 30333
(800) 799-7062
FAX (404) 639-8548
E-mail: siisclear@cdc.gov
Web site: www.cdc.gov/nip/registry
The Immunization Registry Clearinghouse
gathers wide-ranging information on immunization registry development
and implementation, shares immunization strategies that work,
and fosters communication and data sharing between local and state
immunization registries. It promotes using immunization registry
information for action through reminder/recall functions, coverage
assessments, and provider evaluations.
Food and Drug Administration
(FDA)
Center for Biologics Evaluation
and Research
1401 Rockville Pike, HSM
99
Rockville, MD 20852
(800) 835-4709 or (301) 827-1800 (voice information system)
FAX (888) CBER-FAX (fax information system)
E-mail: OCTMA@CBER.FDA.GOV
Web site: www.fda.gov or www.fda.gov/cber
This FDA office maintains a consumer
information hotline to answer questions on vaccine safety and
regulations. It also distributes materials such as guidelines,
Points to Consider, and informational letters to manufacturers.
Its Web site contains current vaccine information, including recalls
and withdrawals of vaccine products.
FDA Freedom of Information
Staff, HFI-35
5600 Fishers Lane
Rockville, MD 20857
(301) 443-2414
FAX (301) 443-1726
Web site: www.fda.gov/foi/foia2.htm
Under the National Childhood Vaccine
Injury Act of 1986 (NCVIA), consumers are entitled to information
from reports describing specific adverse events subsequent to
administration of vaccines outlined within the NCVIA. If more
information on specific Vaccine Adverse Events Reporting System
(VAERS) reports is desired, consumers make a Freedom of Information
Act (FOIA) request using the unique VAERS Report Identification
Numbers contained within the enclosed data set. Items of information
that are not disclosable, such as personal identifiers, will be
purged before the request for additional information is fulfilled.
Charges for search time and copying will be made in accordance
with HHS regulations.
National Vaccine Injury Compensation
Program
Parklawn Building, Room 8A-35
5600 Fishers Lane
Rockville, MD 20857
(800) 338-2382
(301) 443-6593
FAX (301) 443-8196
Web site: www.hrsa.gov/osp/vicp
Congress passed the National Childhood
Vaccine Injury Act (NCVIA) to help ensure vaccine safety and availability,
and to compensate people injured by vaccines. The act established
the National Vaccine Injury Compensation Program (VICP) to compensate
those who suffer certain vaccine-related injuries or death. VICP
also protects doctors and manufacturers from lawsuits while providing
compensation for those injured from vaccines. The program office
distributes an information package detailing how to file a claim,
criteria for eligibility, and what documentation is required.
Vaccine Adverse Event Reporting
System (VAERS)
P.O. Box 1100
Rockville, MD 20849-1100
(800) 822-7967 (24 hours)
Web site: www.fda.gov/cber/vaers.html
or www.cdc.gov/nip/vaers.htm
VAERS is a reporting system created
by the FDA and the CDC to receive and analyze reports about adverse
events that may be associated with vaccines under the National
Childhood Vaccine Injury Act (NCVIA) of 1986. VAERS encourages
the reporting of all clinically significant adverse events following
any vaccine, whether or not the vaccine is believed to be the
cause of the event. Both the CDC and the FDA routinely review
data reported to VAERS. The FDA monitors reports to determine
whether any vaccine lot has a higher than expected reporting rate
of adverse events. The report of an adverse event to VAERS is
not a documentation that a vaccine has caused the event and does
not enter a person into the vaccine injury compensation process.
Because it is difficult to distinguish a coincidental event from
one truly caused by a vaccine, the VAERS database contains events
of both types. Anyone (health care providers or consumers) can
report an adverse event 24 hours a day.
National Vaccine Program
Office (NVPO)
Centers for Disease Control and
Prevention
1600 Clifton Road, NE, MS A-11
Atlanta, GA 30333
(404) 639-4450
FAX (404) 639-3036
E-mail: NVPO@cdc.gov
Web site: www.cdc.gov/od/nvpo
The National Vaccine Program Office
(NVPO) was created in 1986 to coordinate immunization-related
activities between all federal agencies including the Centers
for Disease Control and Prevention, the Food and Drug Administration,
the National Institutes of Health and the Health Resources and
Services Administration.
World Health Organization
(WHO)
Department of Vaccines and Other Biologicals
Avenue Appia 20
1211 Geneva 27, Switzerland
(+41 22) 791 2111
FAX (+41 22) 791 0746
E-mail: info@who.ch
Web site: www.who.int/gpv
or www.who.int/gpv-safety
The Department of Vaccines and
Other Biologicals was established by the World Health Organization
with the goal of protecting all people at risk against vaccine-preventable
diseases. The program is comprised of three units: (1) Expanded
Programme on Immunization; (2) Vaccine Research and Development;
and (3) Vaccine Supply and Quality.
Pan American Health Organization
(PAHO)
Special Program for Vaccines and Immunization (SVI)
525 23rd Street, NW
Washington, DC 20037
(202) 974-3766
FAX (202) 974-3635
E-mail: SVI@PAHO.ORG
Web site: www.paho.org/english/svihome.htm
EPI Newsletter Web site: www.paho.org/english/svi/svipubf.htm
The Special Program for Vaccine
and Immunization (SVI) was established in 1995 to complement the
existing Expanded Programme on Immunization and the Regional System
for Vaccines; to strengthen the activities of vaccine research
development, production, quality control; and to control/eradicate
vaccine preventable diseases in the Americas. It produces the
EPI Newsletter, which facilitates the exchange of ideas and information
concerning immunization programs in the Region.
All Kids Count
750 Commerce Drive, Suite 400
Decatur, GA 30030
(404) 687-5615
FAX (404) 371-0415
E-mail: Info@allkidscount.org
Web site: www.allkidscount.org
A program developed to monitor
and follow-up systems for preschool children, All Kids Count works
closely with the Centers for Disease Control and Prevention to
ensure that immunization information, when combined with other
local, state, and federal efforts, will help increase immunization
rates and the overall health of preschool children. It produces
a quarterly newsletter that is available at no cost.
American Academy of Pediatrics (AAP)
National Headquarters
141 Northwest Point Boulevard
Elk Grove Village, IL 60007-1098 USA
(847) 228-5005
FAX (847) 228-5097
E-mail: kidsdoc@aap.org
Web site: www.aap.org
The American Academy of Pediatrics
is an organization of 45,000 pediatricians dedicated to the health,
safety and well-being of infants, children, adolescents, and young
adults.
American Pharmaceutical Association
(APhA)
2215 Constitution Avenue, NW
Washington DC 20037-2985
(202) 628-4410
FAX (202) 783-2351
Web site: www2.aphanet.org
The American Pharmaceutical Association
is an organization of 50,000 pharmacists and allied health professionals
involved in on-going efforts to educate the public about pharmaceutical
products, including vaccines.
American Public Health Association
(APHA)
1015 15th Street, NW
Washington DC 20005-2605
(202) 789-5600
FAX (202) 789-5661
E-mail: comments@apha.org
Web site: www.apha.org
The American Public Heath Association
is comprised of over 50,000 members from more than 50 health-related
occupations. APHA serves health care providers and the general
public through its scientific and research programs, publications,
annual meeting, educational services and advocacy efforts.
Association of State and Territorial
Health Officials (ASTHO)
1275 K Street NW, Suite 800
Washington DC 20005-4006
(202) 371-9090
FAX (202) 371-9797
E-mail: Sturner@astho.org
Web site: www.astho.org/index.html
The Association of State and Territorial
Health Officials is an organization that represents public health
agencies across the country and in U.S. territories. The Association
is involved in many legislative, educational, scientific, research
and programmatic issues having to do with public health.
Every Child By Two (ECBT)
666 11th St. NW
Washington, DC 20001
(202) 783-7035
E-mail: ecbt@ana.org
Web site: www.ecbt.org
A program of the American Nurses
Foundation, ECBT attempts to raise awareness of the critical need
for timely immunization and fosters putting in place a systematic
way to immunize all of America's children by the age of two. Their
Web site includes the latest immunization research and schedules,
immunization contacts, related periodicals, a nationwide calendar
of events, a plan for action, the ECBT Newsletter, and a list
of current activities.
Immunization Action Coalition (IAC)
1573 Selby Avenue
Saint Paul, MN 55104
(651) 647-9009
FAX (651) 647-9131
E-mail: admin@immunize.org
Web site: www.immunize.org
The Immunization Action Coalition
is a nonprofit organization working to boost immunization rates.
It promotes physician, community, and family awareness of, and
responsibility for, appropriate immunization of people of all
ages against vaccine-preventable diseases. The Hepatitis B Coalition
promotes hepatitis B vaccination for all infants, children, and
adolescents and HbsAg screening for all pregnant women. Other
services includes testing and vaccination for high-risk groups
and education and treatment for hepatitis B carriers. A semi-annual
newsletter containing valuable resources and news is available.
Infectious Disease Society of America
(IDSA)
99 Canal Center Plaza, Suite 210
Alexandria, VA 22314
(703) 299-0200
FAX (703) 299-0204
E-mail: info@idsociety.org
Web site: www.idsociety.org
The Infectious Disease Society
of America seeks to provide comprehensive information on disease
prevention to health care providers and the general public. Recently,
IDSA began the Vaccine Initiative to communicate the benefits
of routine immunization.
Institute for Vaccine Safety
Johns Hopkins School of Public
Health
615 North Wolfe Street, Suite W5515
Baltimore, MD 21207
(410) 955-2955
FAX (410) 502-6733
E-mail: info@vaccinesafety.edu
Web site: www.vaccinesafety.edu
The purpose of the Institute for
Vaccine Safety is to distribute information on vaccines recommended
for routine use, to investigate vaccine safety concerns and to
fund relevant research projects.
National Coalition for Adult Immunization
(NCAI)
Suite 750 / 4733 Bethesda Avenue
Bethesda, MD 20814-5228
(301) 656-0003
FAX (301) 907-0878
E-mail: adultimm@aol.com
Web site: www.nfid.org/ncai/
The National Coalition for Adult
Immunization is composed of more than 95 professional medical
and health care associations, advocacy groups, voluntary organizations,
vaccine manufacturers, and government agencies. The goal of NCAI
is to raise immunization levels for high-risk, adolescent, and
adult target groups by increasing the awareness of physicians,
other health care providers, and the general public about the
need for and benefits of immunization.
National Coalition of Hispanic Health
and Human Services Organization (COSSMHO)
1501 16th Street NW
Washington, DC 20036
(202) 797-4353
FAX (202) 387-5000
Web site: www.cossmho.org
COSSMHO focuses on the health,
mental health, and human services needs of the diverse Hispanic
Communities. COSSMHO's mission is to work with community-based
organizations; universities; federal, state, and local governments;
foundations; and corporations. Research shows that Hispanic children
have low rates of immunization as demonstrated by the 1990 measles
epidemic, during which Hispanic Children were seven times more
at risk than non-Hispanic white counterparts. COSSMHO makes a
concerted effort to ensure that immunizations are made readily
available to the Hispanic Community and addresses barriers to
immunization.
National Council of La Raza
(NCLR)
Center for Health Promotion, Office
Institutional Development
1111 19th Street NW
Suite 1000
Washington, DC 20036
(202) 785-1670, FAX (202) 776-1792
Web site: www.nclr.org
The largest constituency-based
national Hispanic Organization serves as an advocate for Hispanic
Americans as a national umbrella organization for more than 150
formerly affiliated community-based organizations which together
serve Hispanics in 36 states, Puerto Rico, and the District of
Columbia. The NCLR Center for Health Promotion provides technical
assistance to NCLR affiliates and other national, regional, and
local entities which share a commitment to health-related education
and disease prevention in the Hispanic Community. NCLR disseminates
and develops Spanish-language immunization materials.
|